Nifty Pharma Today: Index Falls 2.32% on Broad Selloff

Updated: 8 Oct 2026 • 4:09 pm

Posted by:

Nifty Pharma Today: Index Falls 2.32% on Broad Selloff

Nifty Pharma today closed sharply lower, reflecting a broad-based decline across the pharmaceutical pack. The index ended the session at 25,823.25, down 613.30 points or 2.32%, as every one of its 20 constituents finished in the red.

The session was notable not just for the size of the fall, but for the uniformity of weakness across the basket. From large and mid-sized pharma names to actively traded counters, the sector saw persistent selling pressure from the open and spent the day well below the previous close.

Table of Contents

Sector Index Snapshot

Metric	Value
Index	Nifty Pharma
Current Value	25,823.25
Absolute Change	-613.30
Percentage Change	-2.32%
Opening Value	26,462.15
Previous Close	26,436.55
Day High	26,501.40
Day Low	25,763.05
Market Status	Closed
Last Updated	8 October 2026 at 4:00:00 PM IST
Market Trend	Bearish

Nifty Pharma opened above the previous close at 26,462.15 and briefly touched an intraday high of 26,501.40, but the early strength did not sustain. Selling pressure intensified as the session progressed, dragging the index down to an intraday low of 25,763.05 before it settled at 25,823.25.

That price path matters because it suggests sellers controlled the market after the initial phase of trade. When an index opens firm but closes near the day’s lower zone, it often points to fading risk appetite within that segment. In plain language, buyers were unable to defend higher levels, and the day ended with a clear negative tone.

Quick Summary

Nifty pharma today closed 2.32% lower at 25,823.25 after slipping steadily through the session from its opening zone. The move was broad-based, with all 20 stocks in the index ending in the red, which makes the decline more significant than a fall caused by just one or two names.

The biggest percentage declines came from Mankind Pharma Ltd., Glenmark Pharmaceuticals Ltd., JB Chemicals & Pharmaceuticals Ltd. and Lupin Ltd.. There were no gainers in the index, and market breadth was decisively weak with 100% of constituents closing lower.

High trading activity was visible in names such as JB Chemicals & Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Zydus Lifesciences Ltd., Laurus Labs Ltd. and Sun Pharmaceutical Industries Ltd., showing that the weakness was accompanied by active participation.

For the next session, investors will likely watch whether the index can hold above its intraday low zone of 25,763.05 and whether selling remains broad-based or starts narrowing. A recovery would look stronger if some constituents begin to stabilize instead of the whole pack moving lower together.

Why Nifty Pharma Moved Lower Today

The clearest reason for today’s decline was visible in the internal structure of the index itself: every constituent closed lower. That kind of market action usually reflects sector-wide risk reduction rather than an isolated fall in one or two counters. When 20 out of 20 stocks are in the red, the index decline carries more weight because it is spread across the entire basket.

The second important factor was the gap between the opening tone and the closing result. Nifty Pharma opened at 26,462.15, slightly above the previous close of 26,436.55, and even reached 26,501.40 during the day. But the inability to hold those levels led to a decisive intraday reversal. In market terms, that often indicates that sellers became more aggressive after the initial trade.

The stock-level declines also show that the pressure was not limited to one pocket of the sector. Defensive domestic-facing names, export-oriented players, formulation companies and API-related counters all participated in the fall. Mankind Pharma Ltd. fell 4.80%, Glenmark Pharmaceuticals Ltd. lost 3.95%, JB Chemicals & Pharmaceuticals Ltd. declined 3.87%, and Lupin Ltd. slipped 3.78%.

Further down the list, several widely tracked names also closed meaningfully lower. Divi's Laboratories Ltd. fell 2.37%, Aurobindo Pharma Ltd. declined 2.20%, Dr. Reddy's Laboratories Ltd. dropped 1.98%, Cipla Ltd. lost 1.54%, and Sun Pharmaceutical Industries Ltd. ended 1.19% lower. Even relatively resilient names did not finish in positive territory.

The absence of any advancing stock is itself a major signal. On weaker days, sectors sometimes still produce a handful of positive outliers. That did not happen here. As a result, the pressure on the index appears to have been collective and synchronized, which is why the closing decline remained large.

Market Breadth

Breadth Metric	Reading
Advancing Stocks	0
Declining Stocks	20
Unchanged Stocks	0
Advance-Decline Ratio	0.00
Stocks in Green	0%
Stocks in Red	100%

Market breadth was decisively negative. Not a single constituent closed higher or even unchanged. All 20 stocks ended the day lower, which pushed the advance-decline ratio to 0.00 and left the sector with 100% of stocks in the red.

This kind of breadth usually signals deep weakness rather than a selective correction. If an index falls while many stocks still advance, the decline may be concentrated in a few large names. That was not the case today. The breadth reading suggests the weakness was widespread, and that makes the session more important from a sentiment perspective.

For traders and investors, breadth acts as a health check for the sector. Today’s numbers indicate poor internal strength. In simple terms, the decline was broad, participation was negative, and the closing tone does not point to a narrow or easily dismissible move.

Complete Constituent Performance

Company	CMP	Today's %	Today's Change	Volume	Day High	Day Low	Trend
Mankind Pharma Ltd.	2,380.00	-4.80%	-120.00	783,247	2,510.90	2,347.60	Bearish
Glenmark Pharmaceuticals Ltd.	2,192.20	-3.95%	-90.10	816,490	2,284.00	2,181.20	Bearish
JB Chemicals & Pharmaceuticals Ltd.	2,408.90	-3.87%	-97.10	4,779,224	2,525.50	2,380.00	Bearish
Lupin Ltd.	1,936.90	-3.78%	-76.00	611,469	2,020.90	1,936.90	Bearish
Ajanta Pharma Ltd.	3,435.60	-3.76%	-134.20	83,212	3,580.40	3,411.90	Bearish
Granules India Ltd.	815.05	-3.58%	-30.25	671,015	850.00	810.30	Bearish
Zydus Lifesciences Ltd.	1,112.00	-3.56%	-41.00	1,746,342	1,166.90	1,109.10	Bearish
Biocon Ltd.	350.00	-2.78%	-10.00	2,135,284	361.15	347.20	Bearish
Laurus Labs Ltd.	1,997.90	-2.67%	-54.90	1,394,208	2,055.00	1,997.90	Bearish
Divi's Laboratories Ltd.	9,361.00	-2.37%	-227.00	441,895	9,658.00	9,355.00	Bearish
Gland Pharma Ltd.	3,079.10	-2.27%	-71.50	495,007	3,170.50	3,049.50	Bearish
Aurobindo Pharma Ltd.	1,645.00	-2.20%	-37.00	439,291	1,681.90	1,641.00	Bearish
Torrent Pharmaceuticals Ltd.	4,617.10	-2.10%	-99.10	253,761	4,738.00	4,592.30	Bearish
Dr. Reddy's Laboratories Ltd.	1,180.00	-1.98%	-23.80	2,278,637	1,201.20	1,167.20	Bearish
Abbott India Ltd.	25,580.00	-1.97%	-515.00	5,523	26,270.00	25,475.00	Bearish
Alkem Laboratories Ltd.	5,249.50	-1.89%	-101.00	281,234	5,407.00	5,237.50	Bearish
Natco Pharma Ltd.	795.40	-1.81%	-14.70	312,124	819.00	792.10	Bearish
Cipla Ltd.	1,306.80	-1.54%	-20.40	551,708	1,334.20	1,292.00	Bearish
Sun Pharmaceutical Industries Ltd.	1,759.80	-1.19%	-21.20	1,605,236	1,796.00	1,745.00	Bearish
Ipca Laboratories Ltd.	1,938.40	-0.01%	-0.10	320,842	1,965.40	1,923.00	Bearish

The best performer in relative terms was Ipca Laboratories Ltd., though it still closed marginally lower by 0.01%. The worst performer was Mankind Pharma Ltd., which lost 4.80%.

This table shows how widespread the weakness was. Even stocks that held up comparatively better still ended negative. That matters because relative strength within a weak session often helps identify future resilience, and today only a few names showed anything close to stability.

Top Draggers in Nifty Pharma

Company	Price Change	% Change	Comment on Move
Mankind Pharma Ltd.	-120.00	-4.80%	Sharp decline and weak intraday close near the lower zone made it one of the clearest drags on sentiment.
Glenmark Pharmaceuticals Ltd.	-90.10	-3.95%	A steep percentage loss added to sector pressure and reinforced broad selling across mid-to-large pharma counters.
JB Chemicals & Pharmaceuticals Ltd.	-97.10	-3.87%	Heavy trading volume combined with a sizable decline signaled active selling and amplified the weak tone.
Lupin Ltd.	-76.00	-3.78%	The stock ended at the day low, indicating sustained pressure through the session.
Ajanta Pharma Ltd.	-134.20	-3.76%	Large absolute and percentage loss contributed to the negative breadth across the pack.
Divi's Laboratories Ltd.	-227.00	-2.37%	A substantial rupee decline in a high-priced stock added to downside pressure within the index.

There were no positive contributors today because no constituent closed higher. The drag on the index came from a combination of deep percentage declines and weakness in actively traded names. That combination is often more damaging than isolated declines because it reflects both price pressure and strong participation.

JB Chemicals & Pharmaceuticals Ltd. stands out in this context. It recorded the highest volume among the tracked active names at 47,79,224 shares and also fell 3.87%. When a stock declines on elevated activity, market participants usually read it as stronger conviction on the sell side for that session.

Most Active Stocks in the Sector

Company	Volume	Turnover (Cr)	Today's %	Closing Price
JB Chemicals & Pharmaceuticals Ltd.	4,779,224	1,151.27	-3.87%	2,408.90
Dr. Reddy's Laboratories Ltd.	2,278,637	268.88	-1.98%	1,180.00
Biocon Ltd.	2,135,284	74.73	-2.78%	350.00
Zydus Lifesciences Ltd.	1,746,342	194.19	-3.56%	1,112.00
Sun Pharmaceutical Industries Ltd.	1,605,236	282.49	-1.19%	1,759.80
Laurus Labs Ltd.	1,394,208	278.55	-2.67%	1,997.90

Trading activity remained concentrated in a handful of names, but importantly, those active names also closed lower. That is another sign of weakness. If volumes rise while prices fall across several actively traded counters, it often tells us the down move had broad participation rather than thin liquidity distortions.

Among these, JB Chemicals & Pharmaceuticals Ltd. led both in volume and turnover, while Divi's Laboratories Ltd. and Sun Pharmaceutical Industries Ltd. also saw substantial turnover elsewhere in the session. The activity profile suggests that market attention remained high even as prices slipped.

Sector Performance Comparison

Index	Close	Change	% Change	Relative View vs Nifty Pharma
Nifty IT	27,736.60	-21.20	-0.08%	Outperformed Nifty Pharma
Nifty Metal	11,870.05	-436.65	-3.55%	Underperformed Nifty Pharma
Nifty Bank	54,515.05	-540.50	-0.98%	Outperformed Nifty Pharma
Nifty Financial Services	24,640.45	-275.95	-1.11%	Outperformed Nifty Pharma
Nifty Auto	24,512.70	-626.20	-2.49%	Slightly underperformed Nifty Pharma
Nifty FMCG	43,898.05	-902.80	-2.02%	Outperformed Nifty Pharma
Nifty Pharma	25,823.25	-613.30	-2.32%	Reference
Nifty Mid Select	13,386.75	-370.45	-2.69%	Underperformed Nifty Pharma

Compared with the other sectoral indices in the same list, Nifty Pharma had a weak day. It fell more than Nifty IT, Nifty Bank, Nifty Financial Services and Nifty FMCG. However, it held up slightly better than Nifty Auto, Nifty Mid Select and clearly better than Nifty Metal.

This relative view places pharma in the weaker half of the market for the day, though not at the very bottom. The takeaway is that the sector did not experience isolated weakness in a strong market backdrop; instead, it declined within a generally negative environment, but its own internal breadth made its fall stand out.

Technical Price Structure

The intraday structure was clearly bearish. The index opened at 26,462.15, traded up to 26,501.40, and then slipped to 25,763.05 before closing at 25,823.25. A close much closer to the day’s low than the day’s high generally signals that sellers stayed in control through the latter part of the session.

The opening above the previous close followed by a decisive fall also points to failed early strength. In practical terms, the session formed a weak structure: an initial push higher, loss of momentum, and then continued selling into the close. That pattern often matters because it can influence the tone traders carry into the next trading day.

The nearest reference points visible from today’s session are the day low of 25,763.05 on the downside and the day high of 26,501.40 on the upside. If the index stabilizes, market participants may monitor whether it can move away from the lower band and reclaim ground toward the upper range. If weakness persists, attention may remain on whether the low zone holds.

At the constituent level, several stocks closed near or at their intraday lows, which supports the bearish index reading. Lupin Ltd. ended at 1,936.90, matching its day low. Laurus Labs Ltd. also closed at its low of 1,997.90. Such closes often show limited late-session buying support.

Historical and Period Performance of Key Constituents

While the index itself had a poor day, looking at longer holding-period returns of constituents helps separate short-term pressure from broader trends. Several stocks that fell today still show strong six-month or one-year gains, which means the session may represent profit-taking within a larger uptrend for some names.

Company	1 Month	3 Months	6 Months	1 Year	5 Years
Mankind Pharma Ltd.	3.07%	-4.46%	16.56%	-3.05%	67.33%
Glenmark Pharmaceuticals Ltd.	-11.41%	-1.42%	0.86%	13.63%	315.90%
Lupin Ltd.	-7.97%	-21.23%	-15.57%	1.64%	104.47%
Ajanta Pharma Ltd.	-4.01%	4.78%	26.82%	42.50%	124.37%
Granules India Ltd.	-8.97%	-5.18%	26.50%	48.53%	149.40%
Zydus Lifesciences Ltd.	-2.92%	-3.14%	24.73%	12.78%	102.26%
Biocon Ltd.	-10.78%	-11.85%	0.06%	0.29%	-2.44%
Laurus Labs Ltd.	2.62%	35.99%	84.57%	133.99%	207.77%
Divi's Laboratories Ltd.	-2.23%	38.58%	59.15%	52.95%	84.59%
Gland Pharma Ltd.	4.05%	23.37%	78.14%	57.34%	-20.02%
Aurobindo Pharma Ltd.	-2.78%	5.62%	23.16%	53.62%	130.15%
Torrent Pharmaceuticals Ltd.	-6.91%	-5.12%	14.59%	29.37%	200.27%
Dr. Reddy's Laboratories Ltd.	2.52%	-12.53%	-0.96%	-4.41%	21.67%
Abbott India Ltd.	0.10%	-0.25%	1.27%	-12.52%	20.09%
Alkem Laboratories Ltd.	1.32%	-6.36%	0.07%	-4.44%	33.41%
Natco Pharma Ltd.	-3.68%	-17.69%	-28.50%	-1.68%	-12.19%
Cipla Ltd.	-5.58%	-8.73%	7.48%	-12.57%	42.49%
Sun Pharmaceutical Industries Ltd.	-6.69%	-6.80%	2.64%	7.86%	114.24%
Ipca Laboratories Ltd.	-1.46%	9.99%	34.15%	43.36%	66.05%

Some names remain strong on a medium-term basis despite today’s decline. Laurus Labs Ltd. is up 84.57% in six months and 133.99% in one year. Divi's Laboratories Ltd. has gained 59.15% in six months and 52.95% in one year. Gland Pharma Ltd. has also posted strong six-month and one-year returns.

At the same time, recent one-month and three-month readings show that momentum has become mixed for parts of the sector. That helps explain why a broad corrective day can emerge even when the longer trend in selected constituents remains constructive.

What Investors Should Watch Next

The first thing to watch after a session like this is whether the weakness remains broad-based. If the next trading day again shows all or most constituents in the red, that would indicate the pressure has not yet narrowed. If some stocks begin to stabilize while others stay weak, the sector may start to show internal differentiation.

Second, market participants may track whether the index can stay above today’s low of 25,763.05. Intraday low zones often become reference points after a sharp selloff. Holding above that area could support near-term stabilization, while another close near the low would keep the tone cautious.

Third, the behavior of the most active counters deserves attention. Names such as JB Chemicals & Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Zydus Lifesciences Ltd., Sun Pharmaceutical Industries Ltd. and Laurus Labs Ltd. can often give early clues on sentiment because active trading tends to reveal where conviction is building.

Finally, investors may compare the next session’s move in pharma with other sectoral indices. Today, Nifty Pharma underperformed several major peers such as Nifty IT, Nifty Bank and Nifty Financial Services. Whether that underperformance persists or reverses will be an important signal for sector rotation.

Key Takeaways

Nifty Pharma closed at 25,823.25, down 613.30 points or 2.32%.
The index opened higher but failed to sustain gains and finished near the day’s low.
Market breadth was extremely weak: 0 advancers and 20 decliners.
Mankind Pharma Ltd. was the weakest stock, down 4.80%.
There were no gainers in the index, making the decline fully broad-based.
High activity in falling stocks such as JB Chemicals & Pharmaceuticals Ltd. reinforced the negative tone.
Relative to peer indices, Nifty Pharma underperformed many major sectors, though it did better than Nifty Metal and Nifty Mid Select.
For the next session, the day low of 25,763.05 and the breadth trend will be important signals to watch.

Frequently Asked Questions

1. How did Nifty Pharma close today?

Nifty Pharma closed at 25,823.25 on 8 October 2026, down 613.30 points or 2.32%. The index opened higher than the previous close but weakened through the day and settled near its intraday low, showing a clearly negative closing tone.

2. Why did Nifty Pharma fall today?

The main reason visible in the price action was broad-based selling across the entire sector. All 20 constituents ended lower, which means the decline was not caused by one or two stocks but by widespread weakness across the index basket.

3. Which stock was the top loser in Nifty Pharma today?

Mankind Pharma Ltd. was the top loser in Nifty Pharma today. It closed at 2,380.00, down 120.00 points or 4.80%, making it the weakest performer among all 20 constituents in percentage terms.

4. Were there any gainers in Nifty Pharma today?

No. There were no gainers in Nifty Pharma today. Every constituent in the index closed in the red, which underlines how broad and uniform the sector-wide weakness was during the session.

5. What does today's market breadth in Nifty Pharma indicate?

Today’s breadth was extremely weak, with 0 advancing stocks and 20 declining stocks. That signals broad selling pressure and poor internal strength, because the fall was distributed across the full index rather than concentrated in a small group of shares.

6. How did Nifty Pharma perform compared with other sectoral indices today?

Nifty Pharma fell 2.32%, which was weaker than Nifty IT, Nifty Bank, Nifty Financial Services and Nifty FMCG. However, it performed slightly better than Nifty Auto, Nifty Mid Select and notably better than Nifty Metal.

7. Which were the most active stocks in Nifty Pharma today?

The most active stocks included JB Chemicals & Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Biocon Ltd., Zydus Lifesciences Ltd. and Sun Pharmaceutical Industries Ltd.. Their elevated volumes show that the sector remained actively traded even as prices declined.

8. What does Nifty Pharma track?

Nifty Pharma is a sectoral stock market index that tracks listed pharmaceutical companies within the Indian equity market. It helps investors monitor the overall direction, strength and weakness of the pharma segment through a single benchmark.

9. How many stocks are in Nifty Pharma?

Nifty Pharma had 20 constituents in this session’s reading. All 20 of those stocks closed lower today, which is why the market breadth was especially notable and the decline stood out as fully broad-based.

10. What should investors watch next in Nifty Pharma?

Investors may watch whether the index holds above today’s low of 25,763.05, whether breadth improves from 0 advancers, and whether active names like JB Chemicals & Pharmaceuticals Ltd. and Sun Pharmaceutical Industries Ltd. stabilize or remain under pressure.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.